Literature DB >> 33037527

A Fluorescence Study of the Interaction of Anticancer Drug Molecule Doxorubicin Hydrochloride in Pluronic P123 and F127 Micelles.

Sagar Kumar Behera1, Maneesha Esther Mohanty2, Monalisa Mohapatra3,4.   

Abstract

Drug delivery systems for the sustained and target delivery of doxorubicin to tumor cells are a topic of interest due to the efficacy of the doxorubicin in cancer treatment. The use of polymers such as Pluronic is being studied widely for the formulation of doxorubicin hydrochloride. However, the basic understanding of the physicochemical properties of pluronic micelles in presence of doxorubicin hydrochloride is a very essential topic of study. Doxorubicin hydrochloride is fluorescent; this helped us to study its sensitivity towards the Pluronic microenvironment using the fluorescence technique. In this work, the interaction and place of location of doxorubicin hydrochloride in Pluronic F127 and P123 micelles has been studied extensively using steady-state fluorescence intensity, dynamic fluorescence lifetime, quenching studies, dynamic light scattering, and zeta potential measurements, at different Pluronic concentrations. Using a fluorescence quenching experiment, doxorubicin hydrochloride was found to reside near the hydrophilic PEO corona region of the Pluronic micelles. For both the Pluronic, in the concentration range of study, the micellar size was found to be below 30 nm; this may have a greater advantage for various applications.

Entities:  

Keywords:  Doxorubicin hydrochloride; F127; Fluorescence quenching; Pluronic, P123

Year:  2020        PMID: 33037527     DOI: 10.1007/s10895-020-02630-y

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  25 in total

Review 1.  Chemotherapy-induced cardiotoxicity.

Authors:  Amir Y Shaikh; Jeffrey A Shih
Journal:  Curr Heart Fail Rep       Date:  2012-06

2.  Fluorescence properties of several chemotherapy drugs: doxorubicin, paclitaxel and bleomycin.

Authors:  Najme Sadat Hosseini Motlagh; Parviz Parvin; Fatemah Ghasemi; Fatemeh Atyabi
Journal:  Biomed Opt Express       Date:  2016-05-25       Impact factor: 3.732

3.  Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.

Authors:  Praveena Mohan; Natalya Rapoport
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

4.  Fluorescence properties of doxorubicin in PBS buffer and PVA films.

Authors:  Sunil Shah; Anjali Chandra; Amanjot Kaur; Nirupama Sabnis; Andras Lacko; Zygmunt Gryczynski; Rafal Fudala; Ignacy Gryczynski
Journal:  J Photochem Photobiol B       Date:  2017-03-30       Impact factor: 6.252

5.  High density lipoprotein complexes as delivery vehicles for anticancer drugs.

Authors:  Andras G Lacko; Maya Nair; Sulabha Paranjape; Shemedia Johnso; Walter J McConathy
Journal:  Anticancer Res       Date:  2002 Jul-Aug       Impact factor: 2.480

Review 6.  Doxorubicin cardiomyopathy.

Authors:  Kanu Chatterjee; Jianqing Zhang; Norman Honbo; Joel S Karliner
Journal:  Cardiology       Date:  2009-12-11       Impact factor: 1.869

7.  Quantification of doxorubicin in biofluids using white light excitation fluorescence.

Authors:  John Prakash; Ashok Kumar Mishra
Journal:  J Biophotonics       Date:  2013-04-15       Impact factor: 3.207

8.  Deciphering the fluorescence signature of daunomycin and doxorubicin.

Authors:  K K Karukstis; E H Thompson; J A Whiles; R J Rosenfeld
Journal:  Biophys Chem       Date:  1998-07-27       Impact factor: 2.352

9.  Demonstration of cutaneous doxorubicin extravasation by rhodamine-filtered fluorescence microscopy.

Authors:  P H Duray; C B Cuono; J A Madri
Journal:  J Surg Oncol       Date:  1986-01       Impact factor: 3.454

10.  Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells.

Authors:  Xiaowen Dai; Zhilian Yue; Mark E Eccleston; Johannes Swartling; Nigel K H Slater; Clemens F Kaminski
Journal:  Nanomedicine       Date:  2008-01-31       Impact factor: 5.307

View more
  1 in total

1.  Functionalized Mesoporous Silica as Doxorubicin Carriers and Cytotoxicity Boosters.

Authors:  Carmen Racles; Mirela-Fernanda Zaltariov; Dragos Peptanariu; Tudor Vasiliu; Maria Cazacu
Journal:  Nanomaterials (Basel)       Date:  2022-05-26       Impact factor: 5.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.